Nurse Practitioner, Adult Health · Hackensack, NJ
NPI
1174291058
Since 2021
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
92 2nd St
Hackensack, NJ, 07601
Phone (551) 996-5900
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.7M
431 prescriptions
Company payments, 2025
$1,087
From 24 companies
Medicare prescription drug claims, 2024
In 2024, the drug Kelly Taxeras prescribed most often to Medicare patients was Onureg (Azacitidine), with 37 prescriptions and refills. In total Kelly Taxeras wrote 431 Medicare prescriptions that cost $1.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-02.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Onureg Azacitidine | 37 | 37 | Under 11 | $816K |
| Ciprofloxacin Hcl Generic | 33 | 34 | 14 | $737 |
| Ondansetron Hcl Generic | 28 | 28 | 16 | $139 |
| Jakafi Ruxolitinib Phosphate | 23 | 23 | Under 11 | $401K |
| Acyclovir Generic | 20 | 29 | 11 | $306 |
| Imatinib Mesylate Generic | 18 | 18 | Under 11 | $4,418 |
| Prednisone Generic | 18 | 18 | Under 11 | $57.09 |
| Hydroxyurea Generic | 17 | 23 | Under 11 | $275 |
| Prochlorperazine Maleate Generic | 15 | 15 | 12 | $156 |
| Potassium Chloride Generic | 15 | 15 | 13 | $326 |
| Posaconazole Generic | 13 | 13 | Under 11 | $12K |
| Fluconazole Generic | 11 | 11 | Under 11 | $172 |
| Levofloxacin Generic | 11 | 11 | Under 11 | $181 |
| Venclexta Venetoclax | 11 | 11 | Under 11 | $21K |
Brand drugs: - claims; generic drugs: 325 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kelly Taxeras $1,087 ($1,087 in general payments such as food, travel and fees) from 24 companies. The largest payer was Geron Corporation with $147.
| Company | Payments | Amount |
|---|---|---|
| Geron Corporation GERN | 9 | $147 |
| Taiho Oncology, Inc. 4578.T | 6 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $112 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $80.69 |
| Blueprint Medicines Corporation SNY | 4 | $74.45 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $63.05 |
| Astellas Pharma US Inc 4503.T | 3 | $57.31 |
| Genzyme Corporation SNY | 3 | $51.21 |
| Daiichi Sankyo Inc. 4568.T | 2 | $45.2 |
| GlaxoSmithKline, LLC. GSK | 2 | $36.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.